E1	Procedure:T1 Name:T2 Temporality:E4
E5	Procedure:T5 Name:T6 Temporality:E8
E6	Age:T10 Eq-Comparison:E7
E7	Eq-Comparison:T17 Operator:T8 Value:T13 Temporal-Unit:T26
E8	Eq-Comparison:T18 Operator:T9 Value:T16 Temporal-Unit:T3
E9	Eq-Comparison:T19 Operator:T11 Value:T14 Value2:T15
E2	Condition:T20 Name:T21 Severity:T22
E4	Eq-Comparison:T23 Operator:T7 Operator2:T24 Value:T12 Temporal-Unit:T25
E10	Observation:T27 Name:T28 Eq-Comparison:E9
E3	Temporal-Connection:T4 Arg:E8
E11	Condition:T29 Name:T30
E12	Study:T31 Stability:T32
T1	Procedure 119 111	Immune checkpoint inhibitor therapy
T2	Procedure-Name 119 111	Immune checkpoint inhibitor therapy
T5	Procedure 307 275	Immune checkpoint inhibitor therapy
T6	Procedure-Name 307 275	Immune checkpoint inhibitor therapy
T7	Eq-Operator 136 128	within
T8	Eq-Operator 164 148	>
T9	Eq-Operator 319 287	>
T10	Age 162 146	Age
T11	Eq-Operator 187 164	-
T12	Eq-Value 147 134	2
T13	Eq-Value 168 150	18
T14	Eq-Value 185 163	0
T15	Eq-Value 190 165	3
T16	Eq-Value 322 289	2
T17	Eq-Comparison 168 150	>18
T18	Eq-Comparison 322 289	> 2
T19	Eq-Comparison 187 164	0-
T20	Condition 76 70	cancers
T21	Condition-Name 76 70	cancers
T22	Severity 68 62	Advanced
T23	Eq-Comparison 151 137	within +/- 2wks
T24	Eq-Operator 144 132	+/-
T25	Eq-Temporal-Unit 151 137	wks
T26	Eq-Temporal-Unit 170 151	y
T27	Observation 182 161	ECOG
T28	Observation-Name 182 161	ECOG
T3	Eq-Temporal-Unit 326 292	wks
T4	Temporal-Connection 330 296	ago
T29	Condition 359 323	General vulnerability
T30	Condition-Name 359 323	General vulnerability
T31	Study 400 364	trial
T32	Stability 369 333	affecting
A1	Eq-Operator-Value T7 LTEQ
A2	Eq-Operator-Value T8 GT
A3	Eq-Operator-Value T9 GT
A4	Eq-Operator-Value T11 BETWEEN
A5	Severity-Value T22 severe
A6	Eq-Operator-Value T24 PLUS-MINUS
A7	Eq-Temporal-Unit-Value T25 week
A8	Eq-Temporal-Unit-Value T26 year
A9	Observation-Type-Value T28 measurement
A10	Eq-Temporal-Unit-Value T3 week
A11	Temporal-Connection-Type-Value E3 before
A12	Stability-Value T32 change
R1	Caused-By Arg1:T32 Arg2:E11